BRCA1 and BRCA2 mutations and female fertility

Area of Science:

• Reproductive endocrinology
• Genetics
• Oncology

Background:

• BRCA1 and BRCA2 mutations are associated with increased risks of breast and ovarian cancers.
• The impact of these mutations on female fertility remains an area of ongoing research.
• Understanding fertility effects is crucial for reproductive counseling of mutation carriers.

Purpose of the Study:

• To review recent scientific literature on BRCA1 and BRCA2 mutations.
• To examine the relationship between BRCA1/2 mutations and female fertility outcomes.

Main Methods:

• Systematic review of published studies.
• Analysis of eight relevant studies on female fertility and BRCA mutations.
• Inclusion of studies from the last decade and the preceding ten years.

Main Results:

• Several studies suggest adverse fertility effects, including lower oocyte production and fewer births.
• Four studies reported no significant difference in children ever born between carriers and non-carriers.
• One study indicated elevated natural fertility among mutation carriers in a historical population.

Conclusions:

• Most studies indicate adverse or no significant fertility effects for BRCA1/2 mutation carriers.
• Observed fertility differences are influenced by factors like contraception access.
• The concept of antagonistic pleiotropy, where mutations enhance fertility while reducing survival, was supported in one study.